161 related articles for article (PubMed ID: 35150904)
1. Combined legumain- and integrin-targeted nanobubbles for molecular ultrasound imaging of breast cancer.
Mi X; Guo X; Du H; Han M; Liu H; Luo Y; Wang D; Xiang R; Yue S; Zhang Y; Tan X
Nanomedicine; 2022 Jun; 42():102533. PubMed ID: 35150904
[TBL] [Abstract][Full Text] [Related]
2. Construction of Nucleolin-Targeted Lipid Nanobubbles and Contrast-Enhanced Ultrasound Molecular Imaging in Triple-Negative Breast Cancer.
Fang K; Wang L; Huang H; Lan M; Shen D; Dong S; Guo Y
Pharm Res; 2020 Jul; 37(7):145. PubMed ID: 32666304
[TBL] [Abstract][Full Text] [Related]
3. Preparation and Imaging Investigation of Dual-targeted C
Du J; Li XY; Hu H; Xu L; Yang SP; Li FH
Sci Rep; 2018 Mar; 8(1):3887. PubMed ID: 29497045
[TBL] [Abstract][Full Text] [Related]
4. Asparagine endopeptidase-targeted Ultrasound-responsive Nanobubbles Alleviate Tau Cleavage and Amyloid-β Deposition in an Alzheimer's Disease Model.
Mi X; Du H; Guo X; Wu Y; Shen L; Luo Y; Wang D; Su Q; Xiang R; Yue S; Wu S; Gong J; Yang Z; Zhang Y; Tan X
Acta Biomater; 2022 Mar; 141():388-397. PubMed ID: 35045359
[TBL] [Abstract][Full Text] [Related]
5. Preparation Of Nanobubbles Modified With A Small-Molecule CXCR4 Antagonist For Targeted Drug Delivery To Tumors And Enhanced Ultrasound Molecular Imaging.
Peng Y; Zhu L; Wang L; Liu Y; Fang K; Lan M; Shen D; Liu D; Yu Z; Guo Y
Int J Nanomedicine; 2019; 14():9139-9157. PubMed ID: 32063704
[TBL] [Abstract][Full Text] [Related]
6. Improving ovarian cancer imaging with LHRH-NBs: an experimental study.
Li W; Zhang L; Zhu Y; Zhang J; Shen L; Huang S; Fang S
Arch Gynecol Obstet; 2016 Sep; 294(3):631-8. PubMed ID: 27075493
[TBL] [Abstract][Full Text] [Related]
7. FA-NBs-IR780: Novel multifunctional nanobubbles as molecule-targeted ultrasound contrast agents for accurate diagnosis and photothermal therapy of cancer.
Shen Y; Lv W; Yang H; Cai W; Zhao P; Zhang L; Zhang J; Yuan L; Duan Y
Cancer Lett; 2019 Jul; 455():14-25. PubMed ID: 31018151
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y Y
Li J; Tian Y; Shan D; Gong A; Zeng L; Ren W; Xiang L; Gerhard E; Zhao J; Yang J; Wu A
Biomaterials; 2017 Feb; 116():106-117. PubMed ID: 27914983
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate-loaded PLGA nanobubbles for ultrasound imaging and Synergistic Targeted therapy of residual tumor during HIFU ablation.
Zhang X; Zheng Y; Wang Z; Huang S; Chen Y; Jiang W; Zhang H; Ding M; Li Q; Xiao X; Luo X; Wang Z; Qi H
Biomaterials; 2014 Jun; 35(19):5148-61. PubMed ID: 24680663
[TBL] [Abstract][Full Text] [Related]
10. Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles.
Perera RH; de Leon A; Wang X; Wang Y; Ramamurthy G; Peiris P; Abenojar E; Basilion JP; Exner AA
Nanomedicine; 2020 Aug; 28():102213. PubMed ID: 32348874
[TBL] [Abstract][Full Text] [Related]
11. Ultrasound molecular imaging of ovarian cancer with CA-125 targeted nanobubble contrast agents.
Gao Y; Hernandez C; Yuan HX; Lilly J; Kota P; Zhou H; Wu H; Exner AA
Nanomedicine; 2017 Oct; 13(7):2159-2168. PubMed ID: 28603079
[TBL] [Abstract][Full Text] [Related]
12. RGD-Targeted Ultrasound Contrast Agent for Longitudinal Assessment of Hep-2 Tumor Angiogenesis In Vivo.
Hu Q; Wang XY; Kang LK; Wei HM; Xu CM; Wang T; Wen ZH
PLoS One; 2016; 11(2):e0149075. PubMed ID: 26862757
[TBL] [Abstract][Full Text] [Related]
13. Nanobubble-Affibody: Novel ultrasound contrast agents for targeted molecular ultrasound imaging of tumor.
Yang H; Cai W; Xu L; Lv X; Qiao Y; Li P; Wu H; Yang Y; Zhang L; Duan Y
Biomaterials; 2015 Jan; 37():279-88. PubMed ID: 25453958
[TBL] [Abstract][Full Text] [Related]
14. Preparation of multifunctional nanobubbles and their application in bimodal imaging and targeted combination therapy of early pancreatic cancer.
Yang H; Zhao P; Zhou Y; Li Q; Cai W; Zhao Z; Shen J; Yao K; Duan Y
Sci Rep; 2021 Mar; 11(1):6254. PubMed ID: 33737559
[TBL] [Abstract][Full Text] [Related]
15. Ultrasound molecular imaging of tumor angiogenesis with an integrin targeted microbubble contrast agent.
Anderson CR; Hu X; Zhang H; Tlaxca J; Declèves AE; Houghtaling R; Sharma K; Lawrence M; Ferrara KW; Rychak JJ
Invest Radiol; 2011 Apr; 46(4):215-24. PubMed ID: 21343825
[TBL] [Abstract][Full Text] [Related]
16. Decorrelation Time Mapping as an Analysis Tool for Nanobubble-Based Contrast Enhanced Ultrasound Imaging.
Wegierak D; Cooley MB; Perera R; Wulftange WJ; Gurkan UA; Kolios MC; Exner AA
IEEE Trans Med Imaging; 2024 Jun; 43(6):2370-2380. PubMed ID: 38329864
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetic modeling of PSMA-targeted nanobubbles for quantification of extravasation and binding in mice models of prostate cancer.
Chen C; Perera R; Kolios MC; Wijkstra H; Mischi M; Exner AA; Turco S
Med Phys; 2022 Oct; 49(10):6547-6559. PubMed ID: 36049109
[TBL] [Abstract][Full Text] [Related]
18. Targeted contrast-enhanced ultrasound imaging of tumor angiogenesis with contrast microbubbles conjugated to integrin-binding knottin peptides.
Willmann JK; Kimura RH; Deshpande N; Lutz AM; Cochran JR; Gambhir SS
J Nucl Med; 2010 Mar; 51(3):433-40. PubMed ID: 20150258
[TBL] [Abstract][Full Text] [Related]
19. A Lipopeptide-Based αvβ₃ Integrin-Targeted Ultrasound Contrast Agent for Molecular Imaging of Tumor Angiogenesis.
Yan F; Xu X; Chen Y; Deng Z; Liu H; Xu J; Zhou J; Tan G; Wu J; Zheng H
Ultrasound Med Biol; 2015 Oct; 41(10):2765-73. PubMed ID: 26166460
[TBL] [Abstract][Full Text] [Related]
20. Nanobubbles for enhanced ultrasound imaging of tumors.
Yin T; Wang P; Zheng R; Zheng B; Cheng D; Zhang X; Shuai X
Int J Nanomedicine; 2012; 7():895-904. PubMed ID: 22393289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
